See also: New Drug Approvals for 2004
Lynozyfic (linvoseltamab-gcpt) is a bispecific B-cell maturation antigen...
Zegfrovy (sunvozertinib) is an irreversible EGFR inhibitor for the treatment of...
Harliku (nitisinone) is a hydroxyphenyl-pyruvate dioxygenase inhibitor...
More drug approvals